We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$251M
AUM Growth
+$17.5M
Cap. Flow
+$12.1M
Cap. Flow %
4.81%
Top 10 Hldgs %
73.45%
Holding
118
New
10
Increased
17
Reduced
7
Closed
9

Top Buys

Rank Stock Value
1
MIC
Macquarie Infrastructure Holdings, LLC
MIC
+$8.13M
2
FTAI icon
FTAI Aviation
FTAI
+$4.74M
3
UPLD icon
Upland Software
UPLD
+$3.95M
4
VKTX icon
Viking Therapeutics
VKTX
+$674K
5
QTNT
Quotient Limited Ordinary Shares
QTNT
+$476K

Top Sells

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$4.88M
2
PFE icon
Pfizer
PFE
+$1.63M
3
ATCO
Atlas Corp.
ATCO
+$993K
4
GBT
Global Blood Therapeutics, Inc.
GBT
+$752K
5
SHPG
Shire pic
SHPG
+$460K

Sector Composition

Rank Sector Weight
1 Healthcare 64.84%
2 Financials 7.67%
3 Technology 5.84%
4 Energy 5.67%
5 Industrials 4.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KO icon
51
Coca-Cola
KO
$386B
$615K 0.24%
13,400
– –
WHLRD
52
Wheeler Real Estate Investment Trust Series D Preferred Stock
WHLRD
$64.9M
$603K 0.24%
30,000
– –
EW icon
53
Edwards Lifesciences
EW
$52B
$551K 0.22%
14,673
– –
AXGN icon
54
Axogen
AXGN
$2.77B
$535K 0.21%
18,898
– –
BLCM
55
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$504K 0.2%
5,998
+300
+5% +$29.4K
CDOR
56
DELISTED
Condor Hospitality Trust, Inc. Common Stock
CDOR
$498K 0.2%
50,000
– –
VIVE
57
DELISTED
VIVEVE MED INC
VIVE
$496K 0.2%
100
+4
+4% +$20.8K
CHEKW
58
DELISTED
Check-Cap Ltd. Series A Warrant
CHEKW
$495K 0.2%
66,059
– –
QTNT
59
DELISTED
Quotient Limited Ordinary Shares
QTNT
$490K 0.19%
+2,475
New +$476K
ZGNX
60
DELISTED
Zogenix, Inc.
ZGNX
$461K 0.18%
11,500
+4,400
+62% +$169K
SGYP
61
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$449K 0.18%
201,400
+43,000
+27% +$107K
WPC icon
62
W.P. Carey
WPC
$16.1B
$413K 0.16%
6,126
– –
PCSB
63
DELISTED
PCSB Financial Corporation
PCSB
$381K 0.15%
20,000
– –
CAG icon
64
Conagra Brands
CAG
$7.72B
$377K 0.15%
10,000
– –
HZNP
65
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$365K 0.15%
+25,000
New +$351K
NVLN
66
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$341K 0.14%
109,184
– –
CHRS icon
67
Coherus Oncology
CHRS
$218M
$337K 0.13%
38,320
+4,000
+12% +$42.8K
EIGR
68
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$307K 0.12%
733
+373
+104% +$133K
AIMT
69
DELISTED
Aimmune Therapeutics
AIMT
$304K 0.12%
8,031
+6,031
+302% +$195K
ANCB
70
DELISTED
Anchor Bancorp
ANCB
$304K 0.12%
12,250
– –
TTE icon
71
TotalEnergies
TTE
$191B
$290K 0.12%
5,260
– –
ALIM
72
DELISTED
Alimera Sciences
ALIM
$270K 0.11%
13,533
+266
+2% +$5.19K
XENE icon
73
Xenon Pharmaceuticals
XENE
$5.81B
$266K 0.11%
94,000
+49,000
+109% +$133K
INDP icon
74
Indaptus Therapeutics
INDP
$152M
$180K 0.07%
+16
New +$248K
IRT icon
75
Independence Realty Trust
IRT
$3.84B
$169K 0.07%
16,700
– –
1 2
3
4 5

Similar funds

FA
FMA Advisory Harrisburg, Pennsylvania $268M AUM 30.8% 1-Year Est. Return
KCP
KDI Capital Partners Raleigh, North Carolina $290M AUM 26.07% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return
ISG
Investment Security Group Denver, Colorado $252M AUM 28.26% 1-Year Est. Return
TPCM
Three Peaks Capital Management Castle Rock, Colorado $301M AUM 43.39% 1-Year Est. Return
DCM
DeGreen Capital Management Scottsdale, Arizona $301M AUM 17.24% 1-Year Est. Return
MCL
MIK Capital LP New York $247M AUM 78.02% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

David M. Knott's Q4 2017 Portfolio in Review

As of Q4 2017, David M. Knott held 118 positions worth $251M, up 7.5% from $234M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

David M. Knott deployed $12.1M of net new capital in Q4 2017, opening 10 new positions and adding to 17 existing holdings. Its largest new stake was FTAI Aviation: 302,001 shares worth $5.14M.

By sector, the portfolio is most concentrated in Healthcare at 65% of assets, down from 71% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Ligand Pharmaceuticals, an estimated $4.88M trimmed.

  • David M. Knott's largest Q4 2017 buy was FTAI Aviation: 302,001 shares worth $5.14M.
  • David M. Knott added most to Macquarie Infrastructure Holdings, LLC in Q4 2017, an estimated $8.13M increase.
  • David M. Knott's biggest Q4 2017 reduction was Ligand Pharmaceuticals, cutting an estimated $4.88M.
  • David M. Knott fully exited Atlas Corp. in Q4 2017, selling an estimated $993K.
  • David M. Knott's ten largest holdings make up 73% of its $251M portfolio in Q4 2017.
  • David M. Knott opened 10 new positions and closed 9 in Q4 2017.
  • David M. Knott's portfolio value rose 7.5% quarter-over-quarter to $251M.

Based on David M. Knott's 13F filing for Q4 2017, filed 13 Feb 2018.